Top Research Reports For Morgan Stanley, Intuitive Surgical & Colgate-Palmolive
Zacks Investment Research | Jan 09, 2019 11:30PM ET
Thursday, January 10, 2019
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, Morgan Stanley (NYSE:MS) (MS), Intuitive Surgical (NASDAQ:ISRG), Inc. (ISRG) and Colgate-Palmolive Company (NYSE:CL) (CL). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see today’s research reports here >>>
Morgan Stanley’s shares have lost 12.6% in the last six months, outperforming the Zacks Investment Banking industry, which has lost 16.2% over the same period.The company possesses an impressive earnings surprise history, beating the Zacks Consensus Estimate in each of the trailing four quarters.
The company’s efforts to strengthen wealth management business, focus on corporate lending, steady loan growth, higher interest rates and normalized levels of trading activities will further support revenues. Also, its steady capital deployment plan reflects strong balance sheet position.
However, a slowdown in debt originations will hamper underwriting fee income growth. Further, mounting operating expenses is a major near-term concern for the company.
(You can read the full research report on Morgan Stanley here >>> ).
Shares of Buy-ranked Intuitive Surgical have gained +2.6% in the last six months, outperforming the Zacks Medical Instruments industry which has lost -4.9% over the same period. The company’s robotic platform – da Vinci System – recorded solid growth in recent times. This is led by strong performance in U.S. general surgery procedures and global urologic procedures. Management expects strong contributions from da Vinci in 2019 as well. Commencement of da Vinci sale in Taiwan also adds to the positives.
Management is also optimistic about the company’s collaboration with InTouch Health. On the negative side, the company expects outside U.S. sales to be a bit lumpy in the quarters ahead. These markets are in early stages of adoption.
(You can read the full research report on Intuitive Surgical here >>> ).
Get The News You Want
Shares of Colgate-Palmolive have underperformed the Zacks Consumer Staples industry over the past three months (-1.7% vs. +8.1%). Colgate is smoothly progressing with its cost-savings program. Notably, the Global Growth and Efficiency Program and Funding the Growth initiative are delivering impressive results.
Management approved an expansion and extension of the program through Dec 31, 2019, which will enable it to take advantage of the incremental opportunities while streamlining operations. Further, the company’s meet or beat earnings long track record remains impressive.
It also provided a favorable earnings view for 2018. However, the stock has lagged the industry in the past three months. It has a dismal sales trend, missing estimates in 21 of the last 22 quarters. Management anticipates a tough backdrop due to uncertain global markets and slowing category growth worldwide.
(You can read the full research report on Colgate-Palmolive here >>> ).
Other noteworthy reports we are featuring today include Ecolab (ECL), Keurig Dr Pepper (NYSE:KDP) (KDP) and Prudential Financial (NYSE:PRU) (PRU).
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana. Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly click here>>>
Today's Must Read/h6
Featured Reports/h6
Per the Zacks analyst, Nektar has collaborations with large pharma companies which provide significant amount in fees and a robust pipeline. However, the company relies on partners for revenues.
The Zacks analyst is concerned about capacity expansion outpacing traffic growth at Delta. Unit revenue-related woes are also concerning. However, initiatives to modernize its fleet are encouraging.
Per the Zacks analyst, POSCO will benefit from focus on mergers and business expansion. However, its results will be hurt by the negative effect of exchange rate and interest rate rise.
Per the Zacks analyst, investments in technology upgrade with broadband network infrastructure expansion should continue to drive Telefonica Brasil's leadership position in data and postpaid segments.
Per the Zacks analyst, Prudential continues to put in substantial efforts to boost and expand its international operations, thereby resulting in its overall growth. But rising costs raise concern.
Per the Zacks analyst, Acuity Brands is poised to gain from diversified portfolio of innovative lighting control solutions and energy-efficient luminaries. However, rising input costs raise concern.
Per the Zacks analyst, Nektar has collaborations with large pharma companies which provide significant amount in fees and a robust pipeline. However, the company relies on partners for revenues.
The Zacks analyst is concerned about capacity expansion outpacing traffic growth at Delta. Unit revenue-related woes are also concerning. However, initiatives to modernize its fleet are encouraging.
Per the Zacks analyst, POSCO will benefit from focus on mergers and business expansion. However, its results will be hurt by the negative effect of exchange rate and interest rate rise.
Per the Zacks analyst, investments in technology upgrade with broadband network infrastructure expansion should continue to drive Telefonica Brasil's leadership position in data and postpaid segments.
Per the Zacks analyst, Prudential continues to put in substantial efforts to boost and expand its international operations, thereby resulting in its overall growth. But rising costs raise concern.
Per the Zacks analyst, Acuity Brands is poised to gain from diversified portfolio of innovative lighting control solutions and energy-efficient luminaries. However, rising input costs raise concern.
New Upgrades/h6
Per the Zacks analyst, DISH's excellent customer service is improving retention. Also focus on acquiring and retaining subscribers that are profitable over the long term, is paying off.
Per the Zacks Analyst, E*TRADE's efforts to enhance trading business by introduction of new brokerage products and services.
Per Zacks analyst IDACORP's planned capital investment in excess of $1.4 billion in 2018-2020 time period and rising customer base coupled with increasing usage per customer will boost performance.
Per the Zacks analyst, DISH's excellent customer service is improving retention. Also focus on acquiring and retaining subscribers that are profitable over the long term, is paying off.
Per the Zacks Analyst, E*TRADE's efforts to enhance trading business by introduction of new brokerage products and services.
Per Zacks analyst IDACORP's planned capital investment in excess of $1.4 billion in 2018-2020 time period and rising customer base coupled with increasing usage per customer will boost performance.
New Downgrades/h6
Ecolab expects dull performance in the Energy unit in the coming quarters. The Zacks analyst apprehends that unfavorable pricing, margin woes and competition are the drivers behind the dull outlook.
Per the Zacks analyst, Keurig Dr Pepper is prone to industry headwinds related to soft CSD category and high input costs.
The Zacks analyst is concerned that continued timing and cost overrun issues related to Southern Company (NYSE:SO)'s two mega construction projects will lead to high degree of uncertainty.
Ecolab expects dull performance in the Energy unit in the coming quarters. The Zacks analyst apprehends that unfavorable pricing, margin woes and competition are the drivers behind the dull outlook.
Per the Zacks analyst, Keurig Dr Pepper is prone to industry headwinds related to soft CSD category and high input costs.
The Zacks analyst is concerned that continued timing and cost overrun issues related to Southern Company (NYSE:SO)'s two mega construction projects will lead to high degree of uncertainty.
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.